NXGT yields 25316.46% · PFE yields 6.13%● Live data
📍 NXGT pulled ahead of the other in Year 1
Combined, NXGT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXGT + PFE for your $10,000?
Nexteligent Holdings, Inc. operates as an aggregator of healthcare professional services and technology firms. The company provides professional services in telemedicine, consulting, and financial management. Its Telemedicine Solutions division develops and manages remote care and technology programs aimed at containing costs, improving productivity, and enhancing the quality of medical encounters at healthcare institutions serving the eldercare sector, as well as municipalities and not-for-profit organizations. The company's Financial Services division provides end-to-end revenue cycle management solutions and denials recovery for hospital systems, doctor groups, clinics, and long term care operators. This division also offers turnkey solutions for preventative care services, such as chronic care management, annual wellness visit, transitional care management, behavioral health, and remote telemonitoring. Nexteligent Holdings, Inc. is headquartered in Avon, Connecticut.
Full NXGT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.